Omicron-specific boosters fail to show benefit over original shots, study finds

By Abigail Adcox

Published October 25, 2022 9:12pm ET

Omicron-specific boosters fail to show benefit over original shots, study finds — The newest omicron COVID-19 booster shots from Moderna and Pfizer-BioNTech do not increase neutralizing antibodies, proteins produced in the body that help prevent infection, against omicron subvariants BA.4 and BA.5 compared to four of the original COVID-19 shots, according to a small-scale independent study. Researchers at Columbia University and the University of Michigan found that […]

The newest omicron COVID-19 booster shots from Moderna and Pfizer-BioNTech do not increase neutralizing antibodies, proteins produced in the body that help prevent infection, against omicron subvariants BA.4 and BA.5 compared to four of the original COVID-19 shots, according to a small-scale independent study.